History & Facts

Bacillus Licheniformis 63516 (BL 63516) was discovered in 1986 by Chinese scientist Tielin Wu. After Wu further investigated his observation, he proved the unique strain can balance the naturally occurring bacteria that are located inside intestine. Northeast Pharm start up scientific and medical research on the application of BL 63516 in human.

In 1993, BL 63516 was registered and marketed as OTC drug — an anti-diarrhea drug and prevention intestinal flora imbalance drug, for the first time in China. Northeast Pharm continued to develop the strain, and now it has become the top three probiotic product in China.

Copyright:Northeast Pharm   |   Technical Support:shangbangkeji